Antiplatelet Therapy Testing Assays
16
–
18
of
18
results
16
Abcam (±)-Clopidogrel sulfate, P2Y12 antagonist, 50MG
MW 419.89 g/mol, Purity >99%. Potent, selective P2Y₁₂ antagonist. Potent antithrombotic drug that inhibits ADP-induced platelet aggregation. Clopidogrel is not active in vitro and is the precursor to an active metabolite formed in the liver.
The product is subject to the following: Abcam Restricted Use Statement
17
Abcam (±)-Clopidogrel sulfate, P2Y12 antagonist, 10MG
MW 419.89 g/mol, Purity >99%. Potent, selective P2Y₁₂ antagonist. Potent antithrombotic drug that inhibits ADP-induced platelet aggregation. Clopidogrel is not active in vitro and is the precursor to an active metabolite formed in the liver.
The product is subject to the following: Abcam Restricted Use Statement
18
![Biolegend PE/Cyanine7 anti-mouse P2RY12 [S16007D]; Isotype: Rat IgG2b, κ; Reactivity: Mouse; Apps: FC; Size: 25 μg](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502723003.png-250.jpg)
Biolegend PE/Cyanine7 anti-mouse P2RY12 [S16007D]; Isotype: Rat IgG2b, κ; Reactivity: Mouse; Apps: FC; Size: 25 μg
PE/Cyanine7 anti-mouse P2RY12 [S16007D]; Isotype: Rat IgG2b, κ; Reactivity: Mouse; Apps: FC; Size: 25 μg
- 1
- 2